STOCK TITAN

Compugen (CGEN) awards options and RSUs to board director

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Compugen Ltd. director Mathias Hukkelhoven reported equity awards dated July 29, 2026. He received options for 10,000 Ordinary Shares at an exercise price of $2.2600, expiring July 29, 2036, and an RSU award for 7,500 shares. Both awards vest 25% on October 1, 2027, with the remainder in 12 equal quarterly installments, subject to continued service. Following the RSU grant, he directly holds 17,500 Ordinary Shares.

Positive

  • None.

Negative

  • None.
Insider Hukkelhoven Mathias
Role Director
Type Security Shares Price Value
Grant/Award Share Option (right to buy) F2 10,000 $0.00 $0.00
Grant/Award Ordinary Shares F1 7,500 $0.00 $0.00
Holdings After Transaction: Share Option (right to buy) — 10,000 shares (Direct); Ordinary Shares — 17,500 shares (Direct)
Footnotes (2)
  1. F1. Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
  2. F2. This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
Options granted 10,000 options Share Option (right to buy) for Ordinary Shares granted on July 29, 2026
Option exercise price $2.2600 per share Exercise price of options for 10,000 Ordinary Shares
Option expiration July 29, 2036 Expiration date of the 10,000-share option grant
RSU award size 7,500 RSUs Restricted stock unit award representing Ordinary Shares
Shares held after RSU grant 17,500 Ordinary Shares Direct holdings of Ordinary Shares following the reported RSU award
Initial vesting date October 1, 2027 25% of both options and RSUs vest on this date, subject to service
Remaining vesting schedule 12 quarterly installments Remainder of both option and RSU awards vest in 12 equal quarterly installments
restricted stock unit ("RSU") award financial
"Represents a restricted stock unit ("RSU") award."
Share Option (right to buy) financial
"security_title: Share Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 2.2600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-07-29"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
quarterly installments financial
"the remainder vests in 12 equal quarterly installments thereafter"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider equity awards did Compugen (CGEN) grant to Mathias Hukkelhoven?

Compugen granted 10,000 share options with a $2.2600 exercise price and an RSU award representing 7,500 Ordinary Shares. Both awards follow multi-year vesting schedules tied to Hukkelhoven’s continued service to the company.

How do the new options granted to Compugen (CGEN) director Hukkelhoven vest?

The 10,000 options vest 25% on October 1, 2027, with the remaining options vesting in 12 equal quarterly installments. Vesting is conditioned on Mathias Hukkelhoven’s continued service to Compugen Ltd. throughout the vesting period.

What are the key terms of the Compugen (CGEN) RSU award to Hukkelhoven?

The RSU award covers 7,500 units representing Ordinary Shares. It vests 25% on October 1, 2027, and the rest vests in 12 equal quarterly installments, subject to Hukkelhoven’s continued service to Compugen Ltd.

What is Mathias Hukkelhoven’s Compugen (CGEN) shareholding after these awards?

After the RSU-related entry, Mathias Hukkelhoven directly holds 17,500 Ordinary Shares. In addition, he holds options for 10,000 Ordinary Shares at a $2.2600 exercise price, expiring on July 29, 2036, subject to vesting.

When do the options granted to Compugen (CGEN) director Hukkelhoven expire?

The share options granted to Mathias Hukkelhoven for 10,000 Ordinary Shares carry an exercise price of $2.2600 and have an expiration date of July 29, 2036, assuming they vest and remain outstanding until that time.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hukkelhoven Mathias

(Last)(First)(Middle)
C/O COMPUGEN LTD.
26 HAROKMIM STREET

(Street)
HOLON5885849

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
COMPUGEN LTD [ CGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
[CGEN]
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/29/2026A7,500(1)A$017,500D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Share Option (right to buy)$2.2607/29/2026A10,000 (2)07/29/2036Ordinary Shares10,000$010,000D
Explanation of Responses:
1. Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
2. This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
/s/ Mathias Hukkelhoven07/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)